John M Van Erdewyk, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 525 N Foster St, Mitchell, SD 57301 Phone: 605-995-2000 Fax: 605-995-5645 |
Phillip J Becker, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 525 N Foster St, Mitchell, SD 57301 Phone: 605-995-2000 Fax: 605-995-5645 |
Michael S Haley Jr., MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 525 N Foster St, Mitchell, SD 57301 Phone: 605-995-2000 Fax: 605-995-5645 |
News Archive
A new pharmacological agent demonstrates promising results for the prevention of a wide range of heart rhythm disorders, including both cardiac and brain injury-induced arrhythmias.
People who suffer from dry mouth, or xerostomia, now have a powerful new option for relieving their symptoms. Building on the success of its antioxidant oral care product line, Dallas-based PerioSciences LLC is launching Dry Mouth AO ProGel and a new MILD formula of its Hydrating AO ProRinse. The new products, along with the established Hydrating AO ProRinse and AO ProToothpaste, provide a complete Hydrating Oral Care System.
With the start of the school year around the corner, now is the perfect time for parents to ramp up efforts at infusing their kids' lunches with creative, healthy options. "You don't have to completely cut back on snacks and sugars to ensure that your child eats a well-balanced meal," explains Dr. Joel Lavine, chief of pediatric gastroenterology at NewYork-Presbyterian/Morgan Stanley Children's Hospital.
As the Senate Finance Committee finalizes its health reform proposal, medical-device makers are hoping to convince lawmakers to make one last change, The Wall Street Journal reports. "The Advanced Medical Technology Association, or AdvaMed, the trade group for the larger device manufacturers, wants [Committee Chair Max Baucus of Montana] to reduce $40 billion in fees over the next decade to $15 billion, according to people close to the negotiations. But industry was told that offer is too low.
ZyGEM Corp. Ltd., today announced several developments supporting the advancement of its integrated microfluidics platform designed to dramatically decrease the time, complexity and cost of conducting DNA testing. These include presentations at two key scientific meetings, as well as the issuance of a new patent relating to separation technology that supports and further strengthens ZyGEM's intellectual property portfolio.
› Verified 8 days ago